Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegmolesatide for Anemia in DD-CKD (PANGU-stepup)
NCT07045155Phase 4Recruiting
- Sponsor
- Chinese PLA General Hospital
- Start
- Aug 2025
- Primary completion
- Dec 2027
- Modality
- PEGylated Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of peglmolesatide in anemia of chronic kidney disease (CKD-A), sponsored by Chinese PLA General Hospital. Started Aug 2025; status: recruiting.
02
Drugs
peglmolesatide
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT07045155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07045155.